What is the role of surgery in the treatment of hemoglobinopathy retinopathy?

Updated: Sep 03, 2019
  • Author: Brian A Phillpotts, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Since vitreous hemorrhage and retinal detachment account for most visual loss in hemoglobinopathies, the primary goal in treating proliferative sickle retinopathy is to minimize or eliminate neovascularization. Although treatments are not indicated or required for stages I and II, most advocate the treatment of sickle retinopathy for stage III.

The most widely used therapeutic modalities include laser retinal photocoagulation, retinal cryotherapy, and vitrectomy/membranectomy. The most effective therapeutic modality with minimal postoperative complications appears to be scatter laser retinal photocoagulation.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!